相关实验视频
Updated: May 5, 2026

10:32
Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
32.3K
医学博士培训的财务影响与学术医生的医学博士培训相比
Eva Catenaccio1, Jonathan Rochlin2, Myles H Akabas3
1Department of Neurology, Division of Pediatric Neurology, Perelman School of Medicine at the University of Pennsylvania and the Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
JCI insight
|December 20, 2024
概括
医学博士-博士学位的医生在他们的职业生涯中的钱比医学博士的医生少. 高收入的专业与较少的研究时间相关,但MD-PhD通常选择以研究为重点的领域.
科学领域:
- 医学教育 医学教育
- 医生补偿 医生补偿 医生补偿
- 研究 职业生涯 研究职业生涯
背景情况:
- 医学博士-博士学位课程旨在减少债务和促进研究职业.
- 扩展MD-PhD医生的培训延迟了与MD医生相比获得全薪.
研究的目的:
- 将学术MD-PhD医生与MD医生的终身收入潜力进行比较.
- 检查专业取潜力和MD-PhD医生研究参与之间的联系.
主要方法:
- 分析了47个专业的77,701名学术医生的2020-2021年债务和补偿数据.
- 利用了来自3,025名MD-PhD课程校友的自我报告的研究工作数据.
主要成果:
- 医学博士-博士学位的医生表现出较低的终身收入潜力,而不是相同专业的医学博士.
- 在MD-PhD医生的专业取潜力和研究努力之间存在一个反向关系.
- 学术界的MD-PhD医生更倾向于选择适应更长的研究时间的临床领域.
结论:
- 尽管有经济方面的考虑,MD-PhD医生优先考虑研究参与.
- 专业选择对MD-PhD医生的收入潜力和研究奉献之间的平衡产生重大影响.
更多相关视频
相关概念视频
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
271
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
271
Pharmacokinetic–Pharmacodynamic Relationship: Model Components
229
Pharmacokinetic-pharmacodynamic (PK–PD) modeling is essential in drug development and clinical pharmacology. It provides a quantitative framework to predict drug behavior and response over time. This approach integrates pharmacokinetics (PK), which describes the drug's absorption, distribution, metabolism, and excretion, with pharmacodynamics (PD), which characterizes the drug’s biological effects and mechanisms of action.The disposition kinetics of a drug determine its plasma...
229
Pharmacodynamic Models: Overview
159
Pharmacodynamic (PD) responses describe the interaction between a drug and its biological target, culminating in a physiological effect. These responses can be classified into different types: continuous variables, such as blood glucose levels; categorical outcomes, like survival rates; and time-to-event metrics, such as disease progression. Understanding and modeling PD responses are critical for optimizing drug efficacy and safety.PD models describe the relationship between drug concentration...
159
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
97
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure...
97

